nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—DRD2—nicotine dependence	0.841	1	CbGaD
Norepinephrine—SLC18A1—brain—nicotine dependence	0.0021	0.147	CbGeAlD
Norepinephrine—PAH—brain—nicotine dependence	0.00151	0.106	CbGeAlD
Norepinephrine—SLC18A2—midbrain—nicotine dependence	0.00107	0.0749	CbGeAlD
Norepinephrine—L-DOPA—DRD2—nicotine dependence	0.00105	0.518	CrCbGaD
Norepinephrine—ADRB1—cardiovascular system—nicotine dependence	0.000981	0.0689	CbGeAlD
Norepinephrine—Dopamine—DRD2—nicotine dependence	0.000974	0.482	CrCbGaD
Norepinephrine—ADRA1A—cardiovascular system—nicotine dependence	0.000775	0.0544	CbGeAlD
Norepinephrine—Aggression—Varenicline—nicotine dependence	0.000726	0.182	CcSEcCtD
Norepinephrine—ADRA1B—brain—nicotine dependence	0.000677	0.0476	CbGeAlD
Norepinephrine—SLC18A2—brain—nicotine dependence	0.000671	0.0471	CbGeAlD
Norepinephrine—ADRA1D—brain—nicotine dependence	0.000662	0.0465	CbGeAlD
Norepinephrine—Blood pressure increased—Varenicline—nicotine dependence	0.000638	0.159	CcSEcCtD
Norepinephrine—Photophobia—Varenicline—nicotine dependence	0.000599	0.15	CcSEcCtD
Norepinephrine—DRD2—midbrain—nicotine dependence	0.000594	0.0417	CbGeAlD
Norepinephrine—ADRA2C—midbrain—nicotine dependence	0.000577	0.0405	CbGeAlD
Norepinephrine—SLC22A5—midbrain—nicotine dependence	0.000553	0.0388	CbGeAlD
Norepinephrine—SLC22A1—brain—nicotine dependence	0.0005	0.0351	CbGeAlD
Norepinephrine—ADRB1—brain—nicotine dependence	0.000481	0.0338	CbGeAlD
Norepinephrine—SLC22A3—brain—nicotine dependence	0.000478	0.0335	CbGeAlD
Norepinephrine—ADRA2A—midbrain—nicotine dependence	0.00046	0.0323	CbGeAlD
Norepinephrine—SLC6A2—brain—nicotine dependence	0.000409	0.0287	CbGeAlD
Norepinephrine—SLC18A2—Neuronal System—CHRNA4—nicotine dependence	0.000407	0.00293	CbGpPWpGaD
Norepinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000402	0.00289	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.000399	0.00287	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.000393	0.00282	CbGpPWpGaD
Norepinephrine—ADRA1A—brain—nicotine dependence	0.00038	0.0267	CbGeAlD
Norepinephrine—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.00038	0.00274	CbGpPWpGaD
Norepinephrine—SLC18A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000377	0.00271	CbGpPWpGaD
Norepinephrine—DRD2—brain—nicotine dependence	0.000373	0.0262	CbGeAlD
Norepinephrine—ADRB3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000373	0.00268	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.000365	0.00262	CbGpPWpGaD
Norepinephrine—ADRA2C—brain—nicotine dependence	0.000363	0.0255	CbGeAlD
Norepinephrine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000362	0.0026	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000361	0.0026	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.000355	0.00255	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000349	0.00251	CbGpPWpGaD
Norepinephrine—SLC22A5—brain—nicotine dependence	0.000347	0.0244	CbGeAlD
Norepinephrine—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00034	0.00245	CbGpPWpGaD
Norepinephrine—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000339	0.00244	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.000339	0.00244	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000336	0.00242	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—CYP2A7—nicotine dependence	0.000332	0.00239	CbGpPWpGaD
Norepinephrine—SLC22A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000326	0.00235	CbGpPWpGaD
Norepinephrine—Bradycardia—Varenicline—nicotine dependence	0.000326	0.0815	CcSEcCtD
Norepinephrine—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000325	0.00234	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000324	0.00233	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—FGD1—nicotine dependence	0.000322	0.00232	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000318	0.00228	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.000316	0.00227	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR ligand binding—OPRM1—nicotine dependence	0.000306	0.0022	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000306	0.0022	CbGpPWpGaD
Norepinephrine—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000297	0.00214	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000296	0.00213	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—FGD1—nicotine dependence	0.000292	0.0021	CbGpPWpGaD
Norepinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000291	0.00209	CbGpPWpGaD
Norepinephrine—ADRA2A—brain—nicotine dependence	0.000289	0.0203	CbGeAlD
Norepinephrine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000288	0.00207	CbGpPWpGaD
Norepinephrine—Arrhythmia—Varenicline—nicotine dependence	0.000286	0.0715	CcSEcCtD
Norepinephrine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000279	0.00201	CbGpPWpGaD
Norepinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000278	0.002	CbGpPWpGaD
Norepinephrine—ADRA2C—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000278	0.002	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.000276	0.00199	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000276	0.00198	CbGpPWpGaD
Norepinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000272	0.00196	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000269	0.00193	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000267	0.00192	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000262	0.00188	CbGpPWpGaD
Norepinephrine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000259	0.00186	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000258	0.00185	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.000258	0.00185	CbGpPWpGaD
Norepinephrine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000254	0.00183	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000254	0.00182	CbGpPWpGaD
Norepinephrine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000252	0.00181	CbGpPWpGaD
Norepinephrine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000244	0.00176	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000244	0.00175	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.000243	0.00175	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.000243	0.00175	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000241	0.00174	CbGpPWpGaD
Norepinephrine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000241	0.00173	CbGpPWpGaD
Norepinephrine—Hypertension—Varenicline—nicotine dependence	0.000241	0.0602	CcSEcCtD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000239	0.00172	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000238	0.00171	CbGpPWpGaD
Norepinephrine—Chest pain—Varenicline—nicotine dependence	0.000237	0.0594	CcSEcCtD
Norepinephrine—Anxiety—Varenicline—nicotine dependence	0.000236	0.0592	CcSEcCtD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000236	0.0017	CbGpPWpGaD
Norepinephrine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000234	0.00168	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000233	0.00168	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.000227	0.00163	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000226	0.00162	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000225	0.00162	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000225	0.00162	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000222	0.0016	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR ligand binding—DRD2—nicotine dependence	0.000221	0.00159	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000221	0.00159	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.000221	0.00159	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000221	0.00159	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000221	0.00159	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TAS2R16—nicotine dependence	0.00022	0.00158	CbGpPWpGaD
Norepinephrine—Hyperhidrosis—Varenicline—nicotine dependence	0.00022	0.055	CcSEcCtD
Norepinephrine—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000219	0.00158	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000217	0.00156	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000216	0.00156	CbGpPWpGaD
Norepinephrine—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000215	0.00155	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00021	0.00151	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000209	0.00151	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000206	0.00148	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000205	0.00147	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000205	0.00147	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000205	0.00147	CbGpPWpGaD
Norepinephrine—Dyspnoea—Varenicline—nicotine dependence	0.000203	0.0507	CcSEcCtD
Norepinephrine—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000201	0.00145	CbGpPWpGaD
Norepinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000201	0.00145	CbGpPWpGaD
Norepinephrine—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.000201	0.00144	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0002	0.00144	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000199	0.00143	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000199	0.00143	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000197	0.00142	CbGpPWpGaD
Norepinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000197	0.00142	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000193	0.00139	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—FGD1—nicotine dependence	0.000191	0.00137	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000191	0.00137	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.00019	0.00137	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000189	0.00136	CbGpPWpGaD
Norepinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000189	0.00136	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—FGD1—nicotine dependence	0.000187	0.00134	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000186	0.00134	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000186	0.00134	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000183	0.00132	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000183	0.00132	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—OPRM1—nicotine dependence	0.000182	0.00131	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.00018	0.00129	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000179	0.00129	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000179	0.00129	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—OPRM1—nicotine dependence	0.000178	0.00128	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000177	0.00127	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000174	0.00125	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—FGD1—nicotine dependence	0.000174	0.00125	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000173	0.00124	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—FGD1—nicotine dependence	0.000173	0.00124	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000172	0.00124	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000172	0.00124	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000171	0.00123	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—FGD1—nicotine dependence	0.00017	0.00122	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000169	0.00121	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000168	0.00121	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000166	0.0012	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000165	0.00119	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000163	0.00117	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000163	0.00117	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000161	0.00116	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.00016	0.00115	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00016	0.00115	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.000158	0.00114	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000157	0.00113	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—OPRM1—nicotine dependence	0.000157	0.00113	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000155	0.00111	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—CYP2A7—nicotine dependence	0.000153	0.0011	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000153	0.0011	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKR1B10—nicotine dependence	0.000153	0.0011	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000151	0.00109	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000147	0.00106	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000146	0.00105	CbGpPWpGaD
Norepinephrine—Vomiting—Varenicline—nicotine dependence	0.000145	0.0362	CcSEcCtD
Norepinephrine—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000144	0.00104	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000144	0.00103	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000143	0.00103	CbGpPWpGaD
Norepinephrine—Headache—Varenicline—nicotine dependence	0.000142	0.0356	CcSEcCtD
Norepinephrine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.00014	0.00101	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00014	0.001	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000137	0.000982	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—DRD2—nicotine dependence	0.000131	0.000945	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TAS2R16—nicotine dependence	0.000131	0.00094	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.00013	0.000939	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.00013	0.000936	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00013	0.000933	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000129	0.000931	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—DRD2—nicotine dependence	0.000128	0.000924	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TAS2R16—nicotine dependence	0.000128	0.000919	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—DRD2—nicotine dependence	0.000125	0.0009	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	0.000122	0.000875	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000121	0.00087	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.00012	0.000861	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000119	0.000856	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—DRD2—nicotine dependence	0.000114	0.000817	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000113	0.000811	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000113	0.000809	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.00011	0.000789	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—WASF2—nicotine dependence	0.000107	0.000773	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000106	0.000764	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.00076	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—WASF1—nicotine dependence	0.000103	0.000741	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000103	0.000739	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—FGD1—nicotine dependence	0.000103	0.000737	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000102	0.000736	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000102	0.000732	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000102	0.000731	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—OPRM1—nicotine dependence	0.0001	0.000722	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—FGD1—nicotine dependence	0.0001	0.000721	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	9.94e-05	0.000715	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	9.87e-05	0.00071	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	9.82e-05	0.000707	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—CYP2A7—nicotine dependence	9.58e-05	0.000689	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	9.5e-05	0.000684	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	9.49e-05	0.000683	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.35e-05	0.000673	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	9.34e-05	0.000672	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	9.32e-05	0.000671	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—CYP2A7—nicotine dependence	9.32e-05	0.00067	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—OPRM1—nicotine dependence	9.28e-05	0.000668	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	9.24e-05	0.000665	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—OPRM1—nicotine dependence	9.12e-05	0.000656	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	9.05e-05	0.000651	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	8.97e-05	0.000645	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—CYP2A7—nicotine dependence	8.93e-05	0.000642	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKR1B10—nicotine dependence	8.86e-05	0.000637	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	8.63e-05	0.000621	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	8.62e-05	0.00062	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—FGD1—nicotine dependence	8.61e-05	0.000619	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	8.49e-05	0.000611	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	8.38e-05	0.000603	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	8.31e-05	0.000598	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	8.29e-05	0.000597	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	8.25e-05	0.000593	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	8.15e-05	0.000586	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	7.83e-05	0.000563	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	7.72e-05	0.000555	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	7.71e-05	0.000554	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	7.6e-05	0.000547	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	7.57e-05	0.000544	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	7.54e-05	0.000543	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	7.42e-05	0.000534	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	7.4e-05	0.000532	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	7.35e-05	0.000529	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	7.33e-05	0.000527	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—DRD2—nicotine dependence	7.26e-05	0.000522	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	7.01e-05	0.000504	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	7e-05	0.000504	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	6.87e-05	0.000494	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	6.81e-05	0.00049	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	6.76e-05	0.000486	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	6.74e-05	0.000485	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	6.71e-05	0.000483	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—DRD2—nicotine dependence	6.71e-05	0.000483	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	6.68e-05	0.00048	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—DRD2—nicotine dependence	6.59e-05	0.000474	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—WASF2—nicotine dependence	6.38e-05	0.000459	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	6.32e-05	0.000455	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—WASF2—nicotine dependence	6.24e-05	0.000449	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	6.24e-05	0.000449	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	6.14e-05	0.000442	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—WASF1—nicotine dependence	6.12e-05	0.00044	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	6.06e-05	0.000436	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	6.04e-05	0.000435	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	6.01e-05	0.000432	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—WASF1—nicotine dependence	5.98e-05	0.00043	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	5.9e-05	0.000425	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	5.81e-05	0.000418	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	5.66e-05	0.000407	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	5.58e-05	0.000401	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	5.57e-05	0.000401	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	5.51e-05	0.000396	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	5.46e-05	0.000393	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	5.45e-05	0.000392	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—OPRM1—nicotine dependence	5.39e-05	0.000388	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—WASF2—nicotine dependence	5.36e-05	0.000385	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	5.16e-05	0.000371	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—WASF1—nicotine dependence	5.14e-05	0.00037	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	5.1e-05	0.000367	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	5.07e-05	0.000365	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	5.02e-05	0.000361	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	4.95e-05	0.000356	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	4.8e-05	0.000345	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.62e-05	0.000333	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	4.6e-05	0.000331	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	4.46e-05	0.000321	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	4.37e-05	0.000314	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	4.18e-05	0.000301	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	4.14e-05	0.000298	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—DRD2—nicotine dependence	3.98e-05	0.000286	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	3.95e-05	0.000284	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—DRD2—nicotine dependence	3.89e-05	0.00028	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	3.69e-05	0.000265	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	3.63e-05	0.000261	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	3.22e-05	0.000232	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.99e-05	0.000215	CbGpPWpGaD
